The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase.
T-705 (Favipiravir) is a broad-spectrum antiviral molecule currently in late stage clinical development for the treatment of influenza virus infection. Although it is believed that T-705 potency is mediated by its ribofuranosyl triphosphate (T-705 RTP) metabolite that could be mutagenic, the exact m...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b678aabdaccf4ba8b5c1a3f06d142108 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:b678aabdaccf4ba8b5c1a3f06d142108 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b678aabdaccf4ba8b5c1a3f06d1421082021-11-18T07:37:56ZThe ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase.1932-620310.1371/journal.pone.0068347https://doaj.org/article/b678aabdaccf4ba8b5c1a3f06d1421082013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23874596/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203T-705 (Favipiravir) is a broad-spectrum antiviral molecule currently in late stage clinical development for the treatment of influenza virus infection. Although it is believed that T-705 potency is mediated by its ribofuranosyl triphosphate (T-705 RTP) metabolite that could be mutagenic, the exact molecular interaction with the polymerase of influenza A virus (IAVpol) has not been elucidated. Here, we developed a biochemical assay to measure the kinetics of nucleotide incorporation by IAVpol in the elongation mode. In this assay, T-705 RTP was recognized by IAVpol as an efficient substrate for incorporation to the RNA both as a guanosine and an adenosine analog. Compared to natural GTP and ATP, the discrimination of T-705 RTP was about 19- and 30-fold, respectively. Although the single incorporation of the ribonucleotide monophosphate form of T-705 did not efficiently block RNA synthesis, two consecutive incorporation events prevented further primer extension. In comparison, 3'-deoxy GTP caused immediate chain termination but was incorporated less efficiently by the enzyme, with a discrimination of 4,900-fold relative to natural GTP. Collectively, these results provide the first detailed biochemical characterization to evaluate the substrate efficiency and the inhibition potency of nucleotide analogs against influenza virus polymerase. The combination of ambiguous base-pairing with low discrimination of T-705 RTP provides a mechanistic basis for the in vitro mutagenic effect of T-705 towards influenza virus.Zhinan JinLucas K SmithVivek K RajwanshiBaek KimJerome DevalPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 7, p e68347 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Zhinan Jin Lucas K Smith Vivek K Rajwanshi Baek Kim Jerome Deval The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase. |
description |
T-705 (Favipiravir) is a broad-spectrum antiviral molecule currently in late stage clinical development for the treatment of influenza virus infection. Although it is believed that T-705 potency is mediated by its ribofuranosyl triphosphate (T-705 RTP) metabolite that could be mutagenic, the exact molecular interaction with the polymerase of influenza A virus (IAVpol) has not been elucidated. Here, we developed a biochemical assay to measure the kinetics of nucleotide incorporation by IAVpol in the elongation mode. In this assay, T-705 RTP was recognized by IAVpol as an efficient substrate for incorporation to the RNA both as a guanosine and an adenosine analog. Compared to natural GTP and ATP, the discrimination of T-705 RTP was about 19- and 30-fold, respectively. Although the single incorporation of the ribonucleotide monophosphate form of T-705 did not efficiently block RNA synthesis, two consecutive incorporation events prevented further primer extension. In comparison, 3'-deoxy GTP caused immediate chain termination but was incorporated less efficiently by the enzyme, with a discrimination of 4,900-fold relative to natural GTP. Collectively, these results provide the first detailed biochemical characterization to evaluate the substrate efficiency and the inhibition potency of nucleotide analogs against influenza virus polymerase. The combination of ambiguous base-pairing with low discrimination of T-705 RTP provides a mechanistic basis for the in vitro mutagenic effect of T-705 towards influenza virus. |
format |
article |
author |
Zhinan Jin Lucas K Smith Vivek K Rajwanshi Baek Kim Jerome Deval |
author_facet |
Zhinan Jin Lucas K Smith Vivek K Rajwanshi Baek Kim Jerome Deval |
author_sort |
Zhinan Jin |
title |
The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase. |
title_short |
The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase. |
title_full |
The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase. |
title_fullStr |
The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase. |
title_full_unstemmed |
The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase. |
title_sort |
ambiguous base-pairing and high substrate efficiency of t-705 (favipiravir) ribofuranosyl 5'-triphosphate towards influenza a virus polymerase. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2013 |
url |
https://doaj.org/article/b678aabdaccf4ba8b5c1a3f06d142108 |
work_keys_str_mv |
AT zhinanjin theambiguousbasepairingandhighsubstrateefficiencyoft705favipiravirribofuranosyl5triphosphatetowardsinfluenzaaviruspolymerase AT lucasksmith theambiguousbasepairingandhighsubstrateefficiencyoft705favipiravirribofuranosyl5triphosphatetowardsinfluenzaaviruspolymerase AT vivekkrajwanshi theambiguousbasepairingandhighsubstrateefficiencyoft705favipiravirribofuranosyl5triphosphatetowardsinfluenzaaviruspolymerase AT baekkim theambiguousbasepairingandhighsubstrateefficiencyoft705favipiravirribofuranosyl5triphosphatetowardsinfluenzaaviruspolymerase AT jeromedeval theambiguousbasepairingandhighsubstrateefficiencyoft705favipiravirribofuranosyl5triphosphatetowardsinfluenzaaviruspolymerase AT zhinanjin ambiguousbasepairingandhighsubstrateefficiencyoft705favipiravirribofuranosyl5triphosphatetowardsinfluenzaaviruspolymerase AT lucasksmith ambiguousbasepairingandhighsubstrateefficiencyoft705favipiravirribofuranosyl5triphosphatetowardsinfluenzaaviruspolymerase AT vivekkrajwanshi ambiguousbasepairingandhighsubstrateefficiencyoft705favipiravirribofuranosyl5triphosphatetowardsinfluenzaaviruspolymerase AT baekkim ambiguousbasepairingandhighsubstrateefficiencyoft705favipiravirribofuranosyl5triphosphatetowardsinfluenzaaviruspolymerase AT jeromedeval ambiguousbasepairingandhighsubstrateefficiencyoft705favipiravirribofuranosyl5triphosphatetowardsinfluenzaaviruspolymerase |
_version_ |
1718423185641177088 |